Bicocca Open Archive

Logo unimib boa
BALLARINI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.433
AS - Asia 6.768
EU - Europa 5.789
SA - Sud America 842
AF - Africa 111
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 12
Totale 23.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.154
SG - Singapore 2.333
CN - Cina 1.561
IT - Italia 1.409
VN - Vietnam 1.310
DE - Germania 1.197
RU - Federazione Russa 860
HK - Hong Kong 718
BR - Brasile 699
SE - Svezia 604
IE - Irlanda 409
GB - Regno Unito 321
UA - Ucraina 210
CA - Canada 186
FI - Finlandia 139
IN - India 135
KR - Corea 134
AT - Austria 132
FR - Francia 114
ID - Indonesia 111
JP - Giappone 97
DK - Danimarca 77
TR - Turchia 76
MX - Messico 65
LT - Lituania 63
AR - Argentina 61
PL - Polonia 60
BD - Bangladesh 55
NL - Olanda 52
ZA - Sudafrica 45
AU - Australia 43
IQ - Iraq 42
BE - Belgio 41
ES - Italia 31
EC - Ecuador 27
IR - Iran 27
CH - Svizzera 22
EG - Egitto 21
SA - Arabia Saudita 18
MY - Malesia 17
PK - Pakistan 17
IL - Israele 14
TW - Taiwan 14
UZ - Uzbekistan 14
VE - Venezuela 14
PY - Paraguay 13
CO - Colombia 12
MA - Marocco 11
EU - Europa 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
RO - Romania 9
TN - Tunisia 9
CZ - Repubblica Ceca 8
CR - Costa Rica 7
AO - Angola 6
KW - Kuwait 6
TH - Thailandia 6
UY - Uruguay 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
JO - Giordania 5
KE - Kenya 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
OM - Oman 5
CL - Cile 4
HN - Honduras 4
HU - Ungheria 4
JM - Giamaica 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
KG - Kirghizistan 3
NO - Norvegia 3
PT - Portogallo 3
RS - Serbia 3
AF - Afghanistan, Repubblica islamica di 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CU - Cuba 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
Totale 22.993
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.945
Singapore 1.383
Dallas 1.112
Ashburn 860
Frankfurt am Main 807
Hong Kong 703
Milan 568
Chandler 406
Dublin 395
Ho Chi Minh City 389
Wilmington 335
Hanoi 287
Beijing 275
New York 275
Dearborn 259
Woodbridge 248
Los Angeles 201
Houston 196
Fairfield 192
Jacksonville 187
Santa Clara 174
Hefei 168
Princeton 149
San Jose 147
Vienna 111
Boardman 109
Shanghai 104
Nanjing 100
Seattle 93
Moscow 90
Munich 84
Jakarta 83
Seoul 81
São Paulo 80
Guangzhou 78
Buffalo 76
Chicago 69
Council Bluffs 63
The Dalles 63
Dong Ket 51
Rome 50
Helsinki 48
Vilnius 48
Tokyo 44
Toronto 44
London 41
Montreal 41
Cambridge 38
Carate Brianza 38
Denver 38
Saint Petersburg 38
Turku 37
Warsaw 37
Altamura 36
Haiphong 36
Brooklyn 34
Nuremberg 34
Rio de Janeiro 34
Shenyang 34
Da Nang 32
Lawrence 32
Orem 32
Lachine 30
Brussels 29
Stockholm 29
Hải Dương 28
Kent 28
Pune 28
Daejeon 27
Ha Long 27
Jinan 27
Nanchang 27
Ninh Bình 27
Falls Church 26
Fremont 26
Johannesburg 26
Ottawa 26
Andover 25
Atlanta 25
Biên Hòa 25
Changsha 25
Poplar 25
Quận Bình Thạnh 25
Mexico City 24
Phoenix 24
Chennai 23
Kunming 23
Sacramento 22
Bắc Ninh 21
Columbus 20
Florence 20
Thái Nguyên 20
Tianjin 20
Zhengzhou 20
Hangzhou 19
Shangdi 19
Ankara 18
Can Tho 18
Lappeenranta 18
Vũng Tàu 18
Totale 14.750
Salva come PNG Salva come JPEG
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 532
CIPN and its mechanism of development 524
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 512
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 490
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 453
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 445
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 427
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 418
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 406
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 402
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 388
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 383
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 377
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 376
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 361
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 353
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 338
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 316
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 293
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 290
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 285
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 283
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 281
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 277
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 272
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 261
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 260
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 257
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 253
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 250
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 250
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 247
Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach 247
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 240
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 239
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 239
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 236
Histone deacetylases inhibitors: a new frontier for neuroprotection? 233
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 233
Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation 232
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 229
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 225
Caratterizzazione di un modello di encefalomielite autoimmune sperimentale e ruolo neuroprotettivo del progesterone 224
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 224
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 224
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 222
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 221
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 221
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 221
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 219
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 218
MSCs effect on Dark Agouti rats affected by chronic EAE 217
Therapeutic potential of Mesenchymal Stem Cells for the treatment of type-1 Diabetes. 216
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 212
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 210
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 209
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 206
Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis 206
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 206
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 205
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 202
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 202
Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis 200
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 200
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 194
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 190
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 190
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 188
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 186
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 186
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 186
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation 183
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 183
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 182
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 181
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 179
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 179
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 177
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 167
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 166
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 165
Nose-to-brain delivery of polymeric nanoparticles 164
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 162
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 153
ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation 153
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 152
Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve 142
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis 141
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment 140
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 134
Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? 127
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 126
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS 113
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 113
Blood NfL as a potential axonal damage marker in different CIPN rat models. 110
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 97
MALDI mass spectrometry imaging for in situ analysis of DRGs: Oxaliplatin modifies the tissue proteome 93
null 92
null 80
The different susceptibility to oxaliplatin neurotoxicity in mice is related to change in expression of the anion exchanger SLC4A1 80
Totale 23.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.080 0 0 0 0 0 0 223 220 175 146 123 193
2021/20221.294 104 117 107 137 118 139 56 71 51 80 103 211
2022/20232.289 217 531 299 238 208 324 57 105 138 40 63 69
2023/20241.731 59 65 61 119 197 362 307 98 101 47 57 258
2024/20254.837 262 463 436 226 389 210 327 202 551 673 438 660
2025/20267.929 1.881 1.106 1.613 1.198 1.135 732 264 0 0 0 0 0
Totale 23.943